Home > Qtrly Results > PIRAMAL PHARMA

PIRAMAL PHARMA
Quarterly Results Analysis [Dec2025]

AD     Remove this Ad

PIRAMAL PHARMA Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹2,140 Cr ₹2,044 Cr ₹1,934 Cr ₹2,754 Cr ₹2,204 Cr ₹2,242 Cr ₹1,951 Cr ₹2,552 Cr
Expenses ₹1,944 Cr ₹1,885 Cr ₹1,827 Cr ₹2,193 Cr ₹1,866 Cr ₹1,900 Cr ₹1,747 Cr ₹2,022 Cr
Operating Income ₹196 Cr ₹159 Cr ₹107 Cr ₹561 Cr ₹338 Cr ₹342 Cr ₹204 Cr ₹530 Cr
Other Income ₹43 Cr ₹66 Cr ₹58 Cr ₹42 Cr ₹12 Cr ₹61 Cr ₹20 Cr ₹26 Cr
Interest ₹89 Cr ₹82 Cr ₹86 Cr ₹104 Cr ₹103 Cr ₹108 Cr ₹107 Cr ₹114 Cr
Depreciation ₹213 Cr ₹203 Cr ₹197 Cr ₹243 Cr ₹197 Cr ₹192 Cr ₹185 Cr ₹196 Cr
Profit Before Tax ₹-104 Cr ₹-61 Cr ₹-98 Cr ₹257 Cr ₹50 Cr ₹103 Cr ₹-67 Cr ₹215 Cr
Profit After Tax ₹-146 Cr ₹-114 Cr ₹-100 Cr ₹137 Cr ₹-13 Cr ₹5 Cr ₹-111 Cr ₹89 Cr
EPS ₹-1.03 ₹-0.75 ₹-0.62 ₹1.16 ₹0.03 ₹0.17 ₹-0.67 ₹0.77
Industry Peers & Returns1W1M1Y
PIRAMAL PHARMA -1.5% 7.1% -19.7%
SUN PHARMACEUTICAL INDUSTRIES 0.9% 6.2% 0.6%
DIVIS LABORATORIES 1.8% 4.8% 6.3%
CIPLA -1.3% 0.9% -8.9%
TORRENT PHARMACEUTICALS 1.3% 9.8% 37.7%
DR REDDYS LABORATORIES 1.7% 5.8% 6.7%
MANKIND PHARMA -0.9% -2.7% -13.6%
ZYDUS LIFESCIENCES 0.1% 2.9% -2.5%
LUPIN -0.1% 5.1% 9.6%

PIRAMAL PHARMA Quarterly Revenues

Revenues
Q-o-Q

4.70 %

Y-o-Y

-2.92 %

Quarters Revenues % Change
Dec2025 ₹2,140 Cr
4.70
Sep2025 ₹2,044 Cr
5.69
Jun2025 ₹1,934 Cr
-29.79
Mar2025 ₹2,754 Cr
24.95
Dec2024 ₹2,204 Cr
-1.67
Sep2024 ₹2,242 Cr
14.89
Jun2024 ₹1,951 Cr
-23.56
Mar2024 ₹2,552 Cr -

PIRAMAL PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

23.34 %

Y-o-Y

-42.05 %

Quarters Operating Profit % Change
Dec2025 ₹196 Cr
23.34
Sep2025 ₹159 Cr
48.73
Jun2025 ₹107 Cr
-80.98
Mar2025 ₹561 Cr
66.10
Dec2024 ₹338 Cr
-1.13
Sep2024 ₹342 Cr
67.05
Jun2024 ₹204 Cr
-61.41
Mar2024 ₹530 Cr -
Operating Margins
Q-o-Q

17.91 %

Y-o-Y

-40.27 %

Quarters Operating Margin% % Change
Dec2025 9.15%
17.91
Sep2025 7.76%
40.58
Jun2025 5.52%
-72.90
Mar2025 20.37%
32.96
Dec2024 15.32%
0.52
Sep2024 15.24%
45.42
Jun2024 10.48%
-49.52
Mar2024 20.76% -

PIRAMAL PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Profit After Tax % Change
Dec2025 ₹-146 Cr
Negative
Sep2025 ₹-114 Cr
Negative
Jun2025 ₹-100 Cr
Negative
Mar2025 ₹137 Cr
Positive
Dec2024 ₹-13 Cr
Negative
Sep2024 ₹5 Cr
Positive
Jun2024 ₹-111 Cr
Negative
Mar2024 ₹89 Cr -
PAT Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters PAT Margin(%) % Change
Dec2025 -6.84 %
Negative
Sep2025 -5.58 %
Negative
Jun2025 -5.19 %
Negative
Mar2025 4.98 %
Positive
Dec2024 -0.61 %
Negative
Sep2024 0.24 %
Positive
Jun2024 -5.69 %
Negative
Mar2024 3.5 % -

PIRAMAL PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Negative

Y-o-Y

Negative

Quarters EPS % Change
Dec2025 ₹-1.03
Negative
Sep2025 ₹-0.75
Negative
Jun2025 ₹-0.62
Negative
Mar2025 ₹1.16
3,766.67
Dec2024 ₹0.03
-82.35
Sep2024 ₹0.17
Positive
Jun2024 ₹-0.67
Negative
Mar2024 ₹0.77 -

You may also like the below Video Courses